Christopher Armstrong

Title: Innovations of Christopher Armstrong

Introduction

Christopher Armstrong is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of biochemistry, particularly in the area of protein deacetylation. With a total of 3 patents, his work has implications for understanding cellular processes and potential therapeutic applications.

Latest Patents

Armstrong's latest patents include innovative methods for NAD-dependent deacetylation of lysine residues in proteins. One of his patents discloses methods that involve combining acetylated proteins with isolated Sir2 proteins or fragments that include a core domain of the Sir2 protein. This method can utilize human Sir2 proteins or their fragments. Another patent focuses on identifying agents that alter the NAD-dependent deacetylation activity of Sir2 proteins. The acetylated proteins in these methods can be nuclear proteins, such as histones, or cytoplasmic proteins, showcasing the versatility of his research.

Career Highlights

Armstrong is affiliated with the Massachusetts Institute of Technology, where he continues to advance his research. His work has garnered attention for its potential to influence the understanding of protein modifications and their effects on cellular functions.

Collaborations

Armstrong has collaborated with notable scientists in his field, including Leonard P. Guarente and Shin-ichiro Imai. These collaborations have enriched his research and contributed to the advancement of knowledge in protein biochemistry.

Conclusion

Christopher Armstrong's innovative work in protein deacetylation highlights his role as a significant contributor to biochemistry. His patents reflect a commitment to advancing scientific understanding and potential therapeutic applications.